There are 2949 resources available
Q&A and live discussion
Presenter: Natasha Leighl
Session: Maximising the benefit of immuno-oncology
Resources:
Webcast
FGFR inhibitors
Presenter: Yohann Loriot
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Antibody Drug Conjugate (ADC)
Presenter: Victor Moreno Garcia
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Epigenetic drugs: EZH2, BET and LDSD1
Presenter: Sophie Postel-Vinay
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Future strategies of using radiotherapy as an immune-stimulating agent
Presenter: Fernanda Herrera
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
PRRT and chemo
Presenter: Nick Pavlakis
Session: Peptide Receptor Radionuclide Therapy (PRRT) integration with other therapies
Resources:
Slides
Webcast
Biology and patho-physiology of the blood-brain barrier
Presenter: Rolf Bjerkvig
Session: Blood-brain barrier
Resources:
Slides
Webcast
Clinical relevance
Presenter: Roberta Rudà
Session: Blood-brain barrier
Resources:
Slides
Webcast
Biomarkers
Presenter: Iain McNeish
Session: Checkpoint inhibitors and beyond in gynaecological cancers
Resources:
Slides
Webcast
Immune therapy combinations
Presenter: Sandro Pignata
Session: Checkpoint inhibitors and beyond in gynaecological cancers
Resources:
Slides
Webcast